TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ICUI

ICU Medical Inc

Healthcare · Medical Instruments & Supplies

152.90$ -1.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns ICU Medical Inc (ICUI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.2% of the shares are freely tradable; institutional investors hold 113.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 113.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 25Mio.

Largest Shareholders

Institutions

Institutions ICUI
Name Stake (%) Shares Change (%) Date
BlackRock Inc 14.43 3,608,322 +0.6 03/31/2026
HHG PLC 10.70 2,676,012 +3.9 03/31/2026
Vanguard Portfolio Management, LLC 5.75 1,437,676 +0.0 03/31/2026
Fuller & Thaler Asset Management Inc 4.88 1,220,539 -51.8 03/31/2026
Vanguard Capital Management, LLC 4.45 1,111,875 +0.0 03/31/2026

Funds

Funds ICUI
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.09 1,523,526 +0.0 08/31/2026
Janus Inst Mid Cap Growth CF 4.92 1,230,753 +0.0 06/30/2026
Janus Henderson Enterprise D 4.92 1,230,753 +0.0 08/31/2026
FullerThaler Beh Small-Cap Value SMA 4.49 1,123,972 +4,629.3 06/30/2026
FullerThaler Behavioral Small-Cap Value 4.49 1,123,972 -3.6 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ICUI
Person Role Shares Value As of Type
Bonnell Brian Michael Chief Financial Officer 56,062 8,571,880 $ Sep 1, 2026 direct
Voigtlander Christian B. Chief Operating Officer 37,377 5,714,943 $ Aug 11, 2026 direct
Woolson Daniel VP, GM-Infusion Capital 17,062 2,608,780 $ Aug 13, 2026 direct
Sanzone Virginia Ruth VP, General Counsel 14,604 2,232,952 $ Sep 3, 2026 direct
Finney Elisha W Director 4,871 744,776 $ Aug 11, 2026 direct
Sousa Ben Chief Information Officer 3,076 470,320 $ Aug 12, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 3, 2026 Sanzone Virginia Ruth VP, General Counsel Sell 692 171.52 118,688
Sep 3, 2026 Sanzone Virginia Ruth VP, General Counsel Sell 724 169.53 122,736
Sep 3, 2026 Sanzone Virginia Ruth VP, General Counsel Sell 1,238 168.44 208,523
Sep 3, 2026 Sanzone Virginia Ruth VP, General Counsel Sell 2,202 167.67 369,203
Sep 1, 2026 Bonnell Brian Michael Chief Financial Officer Sell 6,381 175.00 1,116,675
Aug 31, 2026 Bonnell Brian Michael Chief Financial Officer Sell 1,113 173.91 193,567
Aug 31, 2026 Bonnell Brian Michael Chief Financial Officer Sell 4,568 173.44 792,291
Aug 31, 2026 Bonnell Brian Michael Chief Financial Officer Sell 1,914 172.12 329,443
Aug 31, 2026 Bonnell Brian Michael Chief Financial Officer Sell 1,712 171.05 292,843
Aug 13, 2026 Woolson Daniel VP, GM-Infusion Capital Sell 5,417 181.33 982,265
Aug 12, 2026 Sousa Ben Chief Information Officer Sell 2,250 178.32 401,209
Aug 11, 2026 Voigtlander Christian B. Chief Operating Officer Sell 8,929 182.93 1,633,404
Aug 11, 2026 Finney Elisha W Director Sell 378 182.48 68,978

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?